"Designing Growth Strategies is in our DNA"

Biopharmaceuticals Market Size, Share & Industry Analysis, By Type (Immunomodulators {Monoclonal Antibodies, Cytokines}, Enzymes {Hyrolyases, Lyases}, Vaccines {Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated}, Hormones {Human Growth Hormones, Insulin, Thyroid Stimulating Hormones}), By Application (Cardiology, Oncology, Respiratory, Immunology, Neurology), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, & Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI106928

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, By Key Countries/Regions, 2023
    2. New Product Launches, By Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Regulatory Scenario, By Key Countries/Regions
    5. Pipeline Analysis, By Key Players
    6. Impact of COVID-19 on the Market
  5. Global Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
      4. Hormones
        1. Human Growth Hormones
        2. Insulin
        3. Thyroid Stimulating Hormones
        4. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
      4. Hormones
        1. Human Growth Hormones
        2. Insulin
        3. Thyroid Stimulating Hormones
        4. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Other Facilities
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Application
      2. Canada
        1. By Application
  7. Europe Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
      4. Hormones
        1. Human Growth Hormones
        2. Insulin
        3. Thyroid Stimulating Hormones
        4. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Application
      2. Germany
        1. By Application
      3. France
        1. By Application
      4. Italy
        1. By Application
      5. Spain
        1. By Application
      6. Scandinavia
        1. By Application
      7. Rest of Europe
        1. By Application
  8. Asia Pacific Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
      4. Hormones
        1. Human Growth Hormones
        2. Insulin
        3. Thyroid Stimulating Hormones
        4. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
        1. By Application
      2. India
        1. By Application
      3. Japan
        1. By Application
      4. Australia
        1. By Application
      5. Southeast Asia
        1. By Application
      6. Rest of Asia Pacific
        1. By Application
  9. Latin America Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
      4. Hormones
        1. Human Growth Hormones
        2. Insulin
        3. Thyroid Stimulating Hormones
        4. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Application
      2. Mexico
        1. By Application
      3. Rest of Latin America
        1. By Application
  10. Middle East & Africa Biopharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Immunomodulators
        1. Monoclonal Antibodies
        2. Cytokines
        3. Interferons
        4. Others
      2. Enzymes
        1. Hyrdolases
        2. Lyases
        3. Oxidoreductases
        4. Others
      3. Vaccines
        1. Recombinant/Conjugate/Subunit
        2. Inactivated
        3. Live Attenuated
        4. Toxoid
          1. Hormones
            1. Human Growth Hormones
            2. Insulin
            3. Thyroid Stimulating Hormones
            4. Others
          2. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Respiratory
      4. Immunology
      5. Neurology
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
        1. By Application
      2. South Africa
        1. By Application
      3. Rest of Middle East & Africa
        1. By Application
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. AbbVie Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Bristol-Myers Squibb Company
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Bayer AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Lilly
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Sanofi
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. GSK plc
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      12. Takeda Pharmaceutical Company Limited.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01:  Global Biopharmaceuticals Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 02:  Global Biopharmaceuticals Market Value Share (%), by Type, 2023 & 2032

Figure 03:  Global Biopharmaceuticals Market Value Share (%), by Application, 2023 & 2032

Figure 04:  Global Biopharmaceuticals Market Value Share (%), By Distribution Channel, 2023 & 2032

Figure 05:  Global Biopharmaceuticals Market Value (USD billion), by Region, 2023 & 2032

Figure 06:  North America Biopharmaceuticals Market Value (USD billion), By Type, 2023 & 2032

Figure 07:  North America Biopharmaceuticals Market Value Share (%), By Type, 2023

Figure 08:  North America Biopharmaceuticals Market Value (USD billion), By Application, 2023 & 2032

Figure 09:  North America Biopharmaceuticals Market Value Share (%), By Application, 2023

Figure 10:  North America Biopharmaceuticals Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 11:  North America Biopharmaceuticals Market Value Share (%), By Distribution Channel, 2023

Figure 12:  North America Biopharmaceuticals Market Value (USD billion), By Country, 2023 & 2032

Figure 13:  North America Biopharmaceuticals Market Value Share (%), By Country, 2023

Figure 14:  Europe Biopharmaceuticals Market Value (USD billion), By Type, 2023 & 2032

Figure 15:  Europe Biopharmaceuticals Market Value Share (%), By Type, 2023

Figure 16:  Europe Biopharmaceuticals Market Value (USD billion), By Application, 2023 & 2032

Figure 17:  Europe Biopharmaceuticals Market Value Share (%), By Application, 2023

Figure 18:  Europe Biopharmaceuticals Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 19:  Europe Biopharmaceuticals Market Value Share (%), By Distribution Channel, 2023

Figure 20:  Europe Biopharmaceuticals Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 21:  Europe Biopharmaceuticals Market Value Share (%), By Country/ Sub-region, 2023

Figure 22:  Asia Pacific Biopharmaceuticals Market Value (USD billion), By Type, 2023 & 2032

Figure 23:  Asia Pacific Biopharmaceuticals Market Value Share (%), By Type, 2023

Figure 24:  Asia Pacific Biopharmaceuticals Market Value (USD billion), By Application, 2023 & 2032

Figure 25:  Asia Pacific Biopharmaceuticals Market Value Share (%), By Application, 2023

Figure 26:  Asia Pacific Biopharmaceuticals Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 27:  Asia Pacific Biopharmaceuticals Market Value Share (%), By Distribution Channel, 2023

Figure 28:  Asia Pacific Biopharmaceuticals Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 29:  Asia Pacific Biopharmaceuticals Market Value Share (%), By Country/ Sub-region, 2023

Figure 30:  Latin America Biopharmaceuticals Market Value (USD billion), By Type, 2023 & 2032

Figure 31:  Latin America Biopharmaceuticals Market Value Share (%), By Type, 2023

Figure 32:  Latin America Biopharmaceuticals Market Value (USD billion), By Application, 2023 & 2032

Figure 33:  Latin America Biopharmaceuticals Market Value Share (%), By Application, 2023

Figure 34:  Latin America Biopharmaceuticals Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 35:  Latin America Biopharmaceuticals Market Value Share (%), By Distribution Channel, 2023

Figure 36:  Latin America Biopharmaceuticals Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 37:  Latin America Biopharmaceuticals Market Value Share (%), By Country/ Sub-region, 2023

Figure 38:  Middle East & Africa Biopharmaceuticals Market Value (USD billion), By Type, 2023 & 2032

Figure 39:  Middle East & Africa Biopharmaceuticals Market Value Share (%), By Type, 2023

Figure 40:  Middle East & Africa Biopharmaceuticals Market Value (USD billion), By Application, 2023 & 2032

Figure 41:  Middle East & Africa Biopharmaceuticals Market Value Share (%), By Application, 2023

Figure 42:  Middle East & Africa Biopharmaceuticals Market Value (USD billion), By Distribution Channel, 2023 & 2032

Figure 43:  Middle East & Africa Biopharmaceuticals Market Value Share (%), By Distribution Channel, 2023

Figure 44:  Middle East & Africa Biopharmaceuticals Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 45:  Middle East & Africa Biopharmaceuticals Market Value Share (%), By Country/ Sub-region, 2023

Figure 46:  Global Biopharmaceuticals Market Share (%), By Company, 2023

Table 01:  Global Biopharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 02:  Global Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 03:  Global Biopharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 04:  Global Biopharmaceuticals Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 05:  North America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 06:  North America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 07:  North America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 08:  North America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 09:  U.S. Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 10:  Canada Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 11:  Europe Biopharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 12:  Europe Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 13:  Europe Biopharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 14:  Europe Biopharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 15:  U.K. Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 16:  Germany Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 17:  France Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 18:  Italy Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 19:  Spain Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 20:  Scandinavia Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 21:  Rest of Europe Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 22:  Asia Pacific Biopharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 23:  Asia Pacific Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 24:  Asia Pacific Biopharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 25:  Asia Pacific Biopharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26:  China Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 27:  India Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 28:  Japan Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 29:  Australia Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 30:  Southeast Asia Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 31:  Rest of Asia Pacific Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 32:  Latin America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 33:  Latin America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 34:  Latin America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 35:  Latin America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 36:  Brazil Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 37:  Mexico Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 38:  Rest of Latin America Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 39:  Middle East & Africa Biopharmaceuticals Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 40:  Middle East & Africa Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 41:  Middle East & Africa Biopharmaceuticals Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 42:  Middle East & Africa Biopharmaceuticals Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 43:  GCC Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 44:  South Africa Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Table 45:  Rest of Middle East & Africa Biopharmaceuticals Market Revenue (USD billion) Forecast, By Application, 2019-2032

Biopharmaceuticals Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 150
Consulting Services
    How will you benefit from our consulting services ?